FindTrial
Sign In

Outcomes of transconjunctival sutureless 27 gauge vitrectomy for vitreoretinal diseases: a retrospective study based on the case records

Retrospective analyse the efficacy and safety profile of 27 gauge vitrectomy for vitreoretinal diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-17010608
Enrollment
Unknown
Registered
2017-02-10
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitreoretinal disease

Interventions

1:27G vitrectomy

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 74 Years

Inclusion criteria

Inclusion criteria: A retrospective review was performed for all of patients who underwent 3 port, 27 gauge transconjunctival sutureless pars plana vitrectomy at the Sichuan Provincial Peoples Hospital (SPPH, Chengdu, China) by the same surgeon (J.Z.) from June 2015 to March 2016.

Exclusion criteria

Exclusion criteria: Null

Design outcomes

Primary

MeasureTime frame
visual acuity;intraocular pressure;surgical complications;wound healing time;—

Countries

China

Contacts

Public ContactZhong Jie

Sichuan Provincial People's Hospital

13808063276@163.com+86 13808063276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026